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ed May 28, 2013.his study sought to evaluate the association of air pollution with the onset of atrial ﬁbrillation (AF).Background Air pollution in general and more speciﬁcally particulate matter has been associated with cardiovascular events.
Although ventricular arrhythmias are traditionally thought to convey the increased cardiovascular risk, AF may also
contribute.Methods Patients with dual chamber implantable cardioverter-deﬁbrillators (ICDs) were enrolled and followed prospectively.
The association of AF onset with air quality including ambient particulate matter <2.5 mm aerodynamic diameter
(PM2.5), black carbon, sulfate, particle number, NO2, SO2, and O3 in the 24 h prior to the arrhythmia was examined
utilizing a case-crossover analysis. In sensitivity analyses, associations with air pollution between 2 and 48 h prior to
the AF were examined.Results Of 176 patients followed for an average of 1.9 years, 49 patients had 328 episodes of AF lasting 30 s. Positive but
nonsigniﬁcant associations were found for PM2.5 in the prior 24 h, but stronger associations were found with shorter
exposure windows. The odds of AF increased by 26% (95% conﬁdence interval: 8% to 47%) for each 6.0 mg/m3
increase in PM2.5 in the 2 h prior to the event (p ¼ 0.004). The odds of AF were highest at the upper quartile of
mean PM2.5.Conclusions PM was associated with increased odds of AF onset within hours following exposure in patients with known cardiac
disease. Air pollution is an acute trigger of AF, likely contributing to the pollution-associated adverse cardiac
outcomes observed in epidemiological studies. (J Am Coll Cardiol 2013;62:816–25) ª 2013 by the American
College of Cardiology FoundationAir pollution has been linked to overall mortality in epide-
miological investigations (1–4) and most evidence points to
increased cardiovascular disease as the primary driver (5–8).
Although air pollution is composed of multiple pollutants; in
most studies ﬁne particular matter <2.5 mm aerodynamic
diameter (PM2.5) is consistently associated with these cardiac
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, 2012; revised manuscript received May 22,myocardial infarctions (2,4–9). The relative risk of daily
cardiovascular mortality has been shown to be increased
approximately 0.4% to 1.0% with a 10 mg/m3 increase in
mean 24-h PM2.5 (10). In addition, stroke has been associ-
ated with air pollution in several studies, with increased risks
ranging from 0.4% to 18% with a 10 mg/m3 increase in PM2.5
on the day of the event (11–15). PM2.5 is produced by direct
emissions from local and regional sources such as motor
vehicles plus secondary particles from upwind fossil fuel
burning (4). Black carbon (BC), particle number count
(PNC), and NO2 are also produced predominantly by motor
vehicles, while SO4 and ozone are secondary pollutants
produced in atmospheric reactions of emissions from upwind
sources.
These associations between air pollution and health are
generally observed in large population-based studies evalu-
ating epidemiological evidence for death, or hospital
admission data for myocardial infarctions, heart failure, and
stroke. This literature also includes patient-based studies on
ventricular arrhythmias, usually in susceptible populations
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817with low left ventricular ejection fractions and implantable
cardioverter-deﬁbrillators (ICDs) (4,16–20). On the basis of
these investigations, it is generally assumed that the majority
of air pollution’s cardiac effects are on the ventricle, and the
cardiovascular complications of air pollution are mediated
through ventricular arrhythmias, sudden death and wors-
ened heart failure. However, a previous retrospective study
by our group pointed to a possible association between atrial
ﬁbrillation (AF) with rapid ventricular responses and air
pollution. That study was limited by the large proportion of
these patients with single-chamber ICDs that will only
detect AF episodes that caused a rapid ventricular response
(21). Other studies have hinted at an association with AF, in
that air pollution has been associated with some electro-
physiological predictors of AF (22), and also with atrial
premature beats (23,24).
The morbidity and mortality associated with AF is
substantial. AF is responsible for more hospitalizations and
longer hospital stays than any other arrhythmia, and may
also lead to stroke, congestive heart failure, myocardial
infarction, and death (25–31). Thus, AF, even if asymp-
tomatic, is a very important cause of morbidity and
mortality (29,32). Whether air pollution contributes to AF
has been difﬁcult to detect, in large part because many
episodes of AF are asymptomatic or minimally symptom-
atic. Therefore, individuals do not present for emergency
treatment, making this arrhythmia unsuitable for
population-based studies. Even in the case of clinically
recognized AF, the speciﬁc time of onset of these events is
often not well deﬁned. Electrocardiac monitoring studies
are generally limited to short-term monitoring for atrial
arrhythmias and thus a true association may be missed. In
this study, we evaluate the role of acute air pollution
exposures as triggers of AF in a sample of high risk patients
with continuous monitoring of atrial arrhythmias over an
extended period of follow-up. Associations with trafﬁc
related and other air pollutants in the 24 h prior to an AF
event are evaluated, as well as alternative air pollution
exposure windows relative to AF onset.Methods
Patient population. Subjects were recruited between
September 2006 and March 2010 from patients followed at
the Tufts Medical Center Cardiac Arrhythmia Center.
Inclusion criteria included prior implantation of a dual (atrial
and ventricular) chamber ICD and residential zip codes
within a 50-km radius of the Harvard Supersite air quality
monitoring station. Exclusions included age younger than
18 years, chronic AF, lack of follow-up at Tufts Medical
Center, terminal illness, or inability to give informed
consent. The study protocol and informed consent were
approved by the institutional review board at Tufts Medical
Center and the Harvard School of Public Health.
At the initial visit all patients completed an interviewer-
administered questionnaire, including sociodemographiccharacteristics, medical history,
detailed medication, lifestyle, and
smoking history. They were mea-
sured for height and weight. A
comprehensive past and current
medical history, based on the
National Cardiovascular Disease
Data ICDRegistry formwas ﬁlled
out by study coordinators based
on review of medical records.
Arrhythmias. Patients were fol-
lowed with either a clinic visit
or by telephone every 3 months
from study enrollment until June
30, 2010. At these encounters, ICD data which included the
arrhythmia logbook and electrograms were downloaded
directly or with trans-telephonic transmission and printed.
All ICDs were dual chamber and capable of recording the
date, time and real-time electrograms of atrial and ventric-
ular events. In addition to documenting the arrhythmia, the
ICD characterizes each event as atrial or ventricular and
as sustained or nonsustained, and records the total time of
each episode. Heart rate detection and treatment rates for
ventricular arrhythmias are programmed by the physician
according to the speciﬁc needs of the patient. In general,
treatment for ventricular arrhythmia begins at heart rates
above 160 beats/min. In addition to documenting rapid
ventricular episodes, these devices also document and store
electrograms of rapid atrial arrhythmias, even if the ven-
tricular rate remains low.
Arrhythmias documented by the ICD were later reviewed
and interpreted by an electrophysiologist (M.S.L.) blinded
to air quality. These arrhythmias were characterized as
ventricular, sinus tachycardia, AF, atrial arrhythmia other
than AF, or not an arrhythmia. Sinus tachycardia is char-
acterized by gradual onset and a 1:1 atrial to ventricular
association. Acute onset atrial arrhythmias were subdivided
into AF and atrial arrhythmias other than AF. These
arrhythmias generally do not have 1:1 atrial to ventricular
association; typically the atrial rate is much faster than the
ventricular rate. Irregular rapid atrial electrograms were
classiﬁed as AF (Fig. 1).
We restricted our analyses to clinically relevant AF
deﬁned as those lasting 30 s or longer as recommended by
the American Heart Association, the American College of
Cardiology and the Heart Rhythm Society (27,33,34). To
minimize clustering of events and overrepresentation of
clustered events, if time periods between 2 successive AF
episodes were shorter than 60 min, only the ﬁrst episode of
the arrhythmia was included in the analysis. Because of the
possibility of pro-arrhythmia from the implantation of
the ICD, all events occurring within 6 weeks of implant
of the ICD device were excluded. Patients with <90 days of
follow-up were excluded from analysis.
Air quality and weather data. Air quality was measured
hourly at a Harvard Supersite monitor located on the roof of
Figure 1 Electrocardiogram of Atrial Fibrillation
Intracardiac electrogram documenting the initiation of a disorganized atrial arrhythmia. Note the deﬁbrillator documented time and date of arrhythmia onset as well as the
intracardiac electrogram of both the atrium and the ventricle. The rapid and irregular atrial rate is typical of atrial ﬁbrillation. A ¼ atrial; AP ¼ atrial paced event; AS ¼ atrial
sensed event; ATR ¼ atrial tachycardia response (AF); PAC ¼ premature atrial contraction; V ¼ ventricular; VP ¼ ventricular paced event; VS ¼ ventricular sensed event.
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818Countway Library 5 km from Tufts Medical Center. Fine
particle mass (PM2.5) was measured by Tapered Element
Oscillating Microbalance (TEOM, Rupprecht and Patash-
nick, East Greenbush, New York), BC by aethalometer
(McGee Scientiﬁc, Berkeley, California), PNC (number of
particles per cm3) by condensation particle counter (TSI Inc,
Shoreview, Minnesota), and sulfate (SO4) by sulfate
particulate analyzer (Thermo Fisher Scientiﬁc, Waltham,
Massachusetts). Gaseous air pollutants in the Boston
metropolitan area also were measured hourly and averaged
over 3 sites for sulfur dioxide (SO2), 3 sites for nitrogen
dioxide (NO2), and 2 sites for ozone (O3), all operated by
the Massachusetts Department of Environmental Protection
(35). Meteorological data (daily mean temperature, dew
point, and barometric pressure) were obtained from the
hourly surface observations of the National Weather Service
at Logan Airport (East Boston).
Statistical analysis. A case-crossover design allowed for
investigation of the acute effects of exposure to air pollution
(36). The subject’s exposures before the time of the event
(case period) is compared with the distribution of exposure
estimated from separate control periods and the matchedsets are analyzed using conditional logistic regression, thus
each patient serves as his or her own control (9,37–40). For
these case-crossover analyses, only individuals who had AF
in follow-up could be included for analysis.
Case periods were deﬁned by the time prior to onset of
each conﬁrmed arrhythmic event, rounded to the nearest
hour. Control periods (3 to 4 per case) were selected using
a bidirectional time-stratiﬁed approach by matching on
weekday and hour of the day within the same calendar
month (41). Hourly pollution concentrations and weather
conditions were then matched to the case and control time
periods for analysis. With this approach, the odds ratio from
the logistic regression model is a consistent estimator of the
incidence rate ratio. Average air pollution for the 24 h prior
to the AF, modeled as a continuous variable and in quartiles,
was evaluated. Odds of AF associated with air pollution were
estimated with conditional logistic regression, adjusted for
temperature and dew point, and reported as percent
increased odds (odds ratios minus 1 times 100) for an
interquartile range increase in exposure. The interquartile
range reﬂects the range of exposures that the individual
study subjects are likely to experience. Exposure–response
Table 1
Patient Population (176 Subjects Followed
for at Least 90 Days)
All Subjects
(n ¼ 176)*
Subjects With
AF >30 s
(n ¼ 49)*
Age, yrs 65.4 (26–89) 67.9 (35–88)
Male 123 (70%) 33 (67%)
Race
White 164 (93%) 47 (96%)
Black 8 (5%) 2 (4%)
Other 4 (2%) 0 (0%)
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819relationships were examined based on estimated odds of
arrhythmias versus quartiles of air pollution. In sensitivity
analyses, associations with mean air pollution for the prior 2,
6, 12, and 48 h were examined. Associations restricted to
those patients less than the median distance (26 km) from
the air pollution monitoring site, and associations restricted
to patients with 20 or fewer AF events were also explored.
Data management and all statistical analyses were conducted
using SAS software version 9.1.3 (SAS Institute, Cary,
North Carolina).BMI, kg/m2 29.0 (16–57) 27.8 (19–45)
Structural heart disease
Ischemic 91 (52%) 30 (61%)
Nonischemic 52 (30%) 10 (20%)
Other 33 (19%) 9 (18%)
Left ventricular ejection fraction, % 31.4 (10–70) 31.4 (10–70)
History of revascularization
CABG 45 (26%) 15 (31%)
PCI 29 (17%) 13 (27%)*
History of congestive heart failure 96 (55%) 31 (63%)
CHF class
I 19 (11%) 8 (16%)
II 31 (18%) 10 (20%)
III 46 (26%) 13 (27%)
IV 0 0
Indications for implant
Primary prophylaxis 111 (63%) 31 (63%)
Secondary (cardiac arrest or
sustained VT)
33 (19%) 7 (14%)
Syncope apparently arrhythmic 32 (18%) 11 (23%)
Comorbidities
Pulmonary disease 31 (18%) 13 (27%)
Diabetes 47 (27%) 13 (27%)
Hypertension 98 (57%) 27 (56%)
History of AF 51 (29%) 24 (49%)y
Medications
ACE-I or ARB 142 (84%) 41 (87%)
Beta-blocker 158 (93%) 43 (91%)
Antiarrhythmic agents (amiodarone,
sotalol, or others not including
beta-blockers)
28 (17%) 10 (21%)
Platelet aggregation inhibitors 115 (68%) 31 (66%)
Statin 123 (72%) 38 (81%)
Smoking
Current 24 (14%) 5 (11%)
Former 85 (49%) 25 (51%)
Never 66 (38%) 19 (39%)
Lived with smoker 111 (64%) 32 (65%)
History of sleep apnea 25 (15%) 7 (16%)
Values are median (range) or n (%). *Values may not always add up to 176 and 49 because of
missing data. yp < 0.05 between those with and without atrial ﬁbrillation in follow-up.
ACE-I ¼ angiotensin-converting enzyme inhibitors; AF ¼ atrial ﬁbrillation; ARB ¼ angiotensin
receptor blocker; BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting; CHF ¼
congestive heart failure; PCI ¼ percutaneous coronary intervention; VT ¼ ventricular tachycardia.Results
Patient population. Of the 1,143 subjects screened, 843
were excluded, some for more than a single reason. The
majority of the exclusions were for single-chamber ICDs
(n ¼ 502), living outside the 50-km radius of the Harvard
Supersite air quality monitoring station (n ¼ 345) and/or
chronic AF (n ¼ 84). Of the 300 eligible patients, 200 were
enrolled (66%) and 176 were followed for at least 90 days.
The median distance of patients’ residence to the air
pollution monitor was 26 km. Patients were 70% male, 93%
Caucasian, had a mean age of 65 years (range 26 to 89 years)
and a mean body mass index of 29 kg/m2 (range 16 to 57
kg/m2) (Table 1). The mean left ventricular ejection fraction
was 31.4% (range 10% to 70%). Indications for implantation
of an ICD were primary prophylaxis in 111 subjects (63%),
secondary prophylaxis in 33 subjects (19%), and syncope that
clinically appeared arrhythmic, but without documentation
of an arrhythmia in 32 subjects (18%). Twenty-nine percent
of the population had a prior history of paroxysmal AF.
Most patients were on standard pharmacologic therapy for
cardiomyopathies which included beta-blocking agents
(93%), angiotensin-converting enzyme inhibitors or angio-
tensin receptor blockers (84%), antiplatelet agents (68%),
and statins (72%).
For the 176 patients with at least 90 days of follow-up,
the mean follow-up time was 1.9 years. In the course of
the study 9 individuals (of the 200 enrolled) died, including
7 individuals followed for at least 90 days. Two of these
subjects had AF during follow-up. The total time under
observation was 340 person-years.
Arrhythmias. During the study period 328 incident AF
with a duration of 30 s were observed among 49 patients.
The mean number of AF episodes among these 49 patients
was 6.7 (median 4, range 1 to 65, and interquartile range 7).
Patients with AF were more likely to have a past medical
history of AF or percutaneous coronary intervention for
revascularization but were similar in other respects to those
without AF.
Air quality. Daily mean air pollution concentrations during
the study period were modest (Table 2). Mean PM2.5 was
8.4 mg/m3 with only 1 day above the Environmental
Protection Agency (EPA) standard of 35 mg/m3 (maximum
52.4 mg/m3). The trafﬁc-related air pollutants (i.e., PM2.5,
BC, and NO2) were highly correlated (Pearson correlation>0.5), although the strongest correlation (r ¼ 0.82) was
between PM2.5 and SO4, an indicator of secondary, trans-
ported ﬁne particles (Table 2). PNC was negatively corre-
lated with PM2.5 and SO4, but positively correlated with
SO2 and NO2 (indicators of primary emissions).
Table 2
Summary Statistics and Pearson’s Correlation Coefﬁcient of Daily Mean Air Pollutant Concentrations and
Meteorological Variables in Boston During the Study Period From September 1, 2006, to June 30, 2010
Summary Statistics Pearson Correlation Coefﬁcient
# Days Mean 25th 50th 75th PM2.5 SO4
2 BC PNC
Particles
PM2.5, mg/m
3 1,213 8.4 5.3 7.2 10.2 1.00 0.82 0.64 0.17
SO4
2, mg/m3 964 2.2 1.0 1.6 2.6 1.00 0.51 0.30
BC, mg/m3 1,315 0.59 0.36 0.52 0.76 1.00 0.04
PNC, 1,000/cm3 1,318 14.9 10.1 14.6 18.6 1.00
Gases
SO2, ppb 1,399 3.2 1.8 2.7 4.0 0.22 0.13 0.23 0.58
NO2, ppb 1,399 16.1 11.9 15.2 19.2 0.37 0.24 0.59 0.47
O3, ppb 1,399 24.8 17.5 24.3 31.5 0.18 0.22 0.21 0.39
Weather
Temperature, C 1,398 10.6 3.4 11.0 18.3 0.31 0.37 0.24 0.74
Dew point temperature, C 1,398 3.5 3.7 4.1 11.9 0.34 0.41 0.35 0.72
BC ¼ black carbon; PM2.5 ¼ particulate matter <2.5 mm aerodynamic diameter; PNC ¼ particle number count.
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820Air quality and AF. Increased odds were found between
mean PM2.5 in the prior 24 h and AF (Table 3). The
strongest increased odds were a 14% increase (95%
conﬁdence interval [CI]: –3% to 34%) for each 5.0 mg/m3
increase in 24-h mean PM2.5. Stronger increased odds were
found with shorter exposure periods before the AF event
(Fig. 2) with the strongest odds in the 2 h moving average
(26%; 95% CI: 8% to 47%) (Table 3) and effectively no
association with mean over the previous 48 h (Fig. 2). A
similar pattern was observed for BC, NO2, and PNC in that
increased relative odds were also found for 2-h moving
averages compared to the 24-h moving average. In quartile
analysis there was an apparent exposure response effect inTable 3
Percent Change in Risk of ICD Detected Arrhythmias Assoc
Mean Air Pollution in the 2 and 24 h Prior to Arrhythmic Ev
Hours Prior Interquartile Range
24-h moving average
Particulates
PM2.5, mg/m
3 24 5.0
BC, mg/m3 24 0.39
PNC, 1,000/cm3 24 8.4
SO4, mg/m
3 24 1.6
Gases
NO2, ppb 24 7.3
SO2, ppb 24 2.1
O3, ppb 24 14.0
2-h moving average
Particulates
PM2.5, mg/m
3 2 6.0
BC, mg/m3 2 0.49
PNC, 1,000/cm3 2 10.9
SO4, mg/m
3 2 1.7
Gases
NO2, ppb 2 10.0
SO2, ppb 2 2.2
O3, ppb 2 17.0
ICD ¼ implantable cardioverter-deﬁbrillator; other abbreviations as in Table 3.that the highest risk of AF was in the highest quartile of
PM2.5 (Fig. 3).
In sensitivity analyses restricted to the 25 patients (174
AF events) living closer than 26 km from the air pollution
monitoring site, a stronger association was found with air
pollution in the prior 2 h for PM2.5 (42% increased odds
compared with 26% in the whole population), BC (22%
increased odds compared with 16% in the whole pop-
ulation), and NO2 (28% increased odds compared with 18%
in the whole population) (Fig. 4). In analysis restricted to the
25 subjects with no history of AF prior to study enrollment
(124 episodes of AF) the associations with PM2.5 and BC
were similar and stronger for NO2 (Fig. 5).iated With Each Interquartile Range Increase in
ent, Adjusted for Temperature and Dew Point
% Change 95% Conﬁdence Interval p Value
14 3% to 34% 0.12
6 10% to 26% 0.47
12 19% to 56% 0.49
0 14% to 15% 0.96
8 10% to 31% 0.41
6 13% to 29% 0.54
18 12% to 56% 0.27
26 8% to 47% 0.004
16 2% to 32% 0.021
24 4% to 61% 0.099
2 10% to 16% 0.71
18 1% to 39% 0.056
4 10% to 20% 0.59
3 20% to 31% 0.83
Figure 2 Risk of Atrial Fibrillation With Air Pollution
Percent increase in the occurrence (odds) of atrial ﬁbrillation episodes associated with increase in air pollution (particulate matter<2.5 mm aerodynamic diameter [PM2.5], black
carbon, and NO2) as a function of moving average in hours prior to event. Stronger increased odds were found with shorter exposure periods before the atrial ﬁbrillation event
with the strongest odds in the 2 h moving average.
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821To ensure that patients with many events were not driving
the positive association, the analysis was repeated with the
exclusion of those individuals with >20 AF episodes (3
individuals). Among these 46 patients (204 AF events), the
increased odds of air pollution were either similar or of
greater magnitude for PM2.5 (28%; 95% CI: 4% to 59%),
BC (26%; 95% CI: 7% to 49%), NO2 (48%; 95% CI: 19% to
85%), and PNC (44%; 95% CI: 1% to 105%). There was
still no association with SO4, SO2, or O3.Discussion
Fine PM was an acute trigger of AF in this prospective
study. This study is unique for its ability to capture allFigure 3 Risks of Atrial Fibrillation Relative to Quartile of Pollution i
This ﬁgure models the predictors as quartiles and plots each quartile at the median conce
2-h moving averages of air pollution (particulate matter <2.5 mm aerodynamic diameter
exposure response effect in that the highest risk of atrial ﬁbrillation was in the highest q(including asymptomatic) atrial arrhythmias in a population
at high risk for subclinical and clinical cardiac events. In
addition, this study is able to specify the precise time of AF
onset, and match time of onset with hourly ambient air
pollution measurements. In many epidemiological studies
the time window for cardiovascular effects of pollution is
over days to years. However, we observed evidence of
a shorter time window of increased exposure of 2 h, which
was associated with an acutely increased risk. This short time
window may be due to the nature of AF mechanism
compared to other cardiovascular endpoints such as
myocardial infarction or congestive heart failure or to the
more precise timing of the events as is present in current
ICD data collection.n the 2 h Prior to the Arrhythmia
ntration for that quartile. Percent increased occurrence (odds) of atrial ﬁbrillation for
[PM2.5], black carbon, and NO2) versus quartile medians. There was an apparent
uartile of PM2.5.
Figure 4 Risk of Atrial Fibrillation With Air Pollution in Patients Living Within 26 km of the Air Pollution Monitoring Site
In analyses restricted to the 25 patients (174 atrial ﬁbrillation events) living closer than 26 km from the air pollution monitoring site, a stronger association was found with air
pollution in the prior 2 h for particulate matter <2.5 mm aerodynamic diameter (PM2.5; 42% increased odds compared with 26% in the whole population), black carbon (22%
increased odds compared with 16% in the whole population), and NO2 (28% increased odds compared with 18% in the whole population).
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822Atrial ﬁbrillation may be triggered by changes in autonomic
tone (42–45), inﬂammation and oxidative stress (46–48),
atrial ischemia (49), and atrial pressures changes (27,49,50).
Acute alterations in sympathetic and parasympathetic tone
and reduced heart rate variability is well documented in air
pollution studies in humans (51–53), and animals (54,55).
Increases in particulate air pollution have also been linked to
inﬂammation (56–58). Cardiac ischemia is worsened by air
pollution (59,60). And ﬁnally increases in right ventricular
and thus likely right atrial pressures are seen with increases in
particulate matter (61). Thus, it biologically plausible that
particulate air pollution can acutely trigger AF.
In addition to the strongest odds found with PM2.5, BC
was associated with AF in the 2-h moving average prior to
AF. PM2.5 incorporates pollution from a multiple sources,
both direct emissions from motor vehicles and other local
and regional sources and secondary particles from upwindFigure 5 Risk of Atrial Fibrillation With Air Pollution in Patients With
In analysis restricted to the 25 subjects with no history of atrial ﬁbrillation prior to study
matter <2.5 mm aerodynamic diameter (PM2.5) and black carbon were similar and strongfossil fuel combustion (51,53,62). BC is mainly a marker of
local and regional vehicular emissions. Other pollutants
associated with vehicular emissions, PNC and NO2 were
also associated with AF, but did not reach statistical
signiﬁcance. Pollutants not associated with motor vehicular
pollution (SO4, SO2, O3) were not associated with AF.
A strength of this study was the ability to precisely deﬁne
the time of onset of AF. Because AF may be asymptomatic
or of short duration, it is important to accurately and
precisely deﬁne the time of onset of these events.
Misalignment of air pollution exposures with acute cardiac
events has been shown to produce an underestimate of the
association and can mask true associations (63). Another
strength of this study is the hourly pollution measurements
obtained in the Boston area, allowing for more accurate
determination of association of air quality and arrhythmias.
These precise hourly measurements allowed for examinationout a Prior History of Atrial Fibrillation
enrollment (124 episodes of atrial ﬁbrillation) the associations with particulate
er for NO2 compared with all patients.
JACC Vol. 62, No. 9, 2013 Link et al.
August 27, 2013:816–25 Air Pollution and Atrial Fibrillation
823of acute triggering (as little as 2-h moving averages) of AF,
in contrast to most previous studies that have relied on
integrated calendar day mean air pollution data.
AF is responsible for more hospitalizations and longer
stays than any other arrhythmia, and may lead to stroke,
congestive heart failure, and myocardial infarction (25–28).
AF is the most common arrhythmia in the United States
and most other countries (27,64). The morbidity and
mortality of AF is largely based on the risk of embolic
events, the induction of heart failure and myocardial
ischemia, and not on whether it causes arrhythmic symp-
toms. Given the known associations of AF and adverse
cardiac outcomes (25–29), and the results of this study it is
likely that at least a portion of air pollution’s adverse
cardiovascular effects are mediated by AF. Therefore, it is
quite likely that AF contributes to the morbidity and
mortality that has been associated with air pollution.
Most concerning is that the higher odds ofAFwere observed
at air quality levels well under ambient air quality standards.
The EPA 24-h standard for PM2.5 is 35 mg/m
3 (65). In the
current study the maximum PM2.5 was 52.4 mg/m
3 and the
75th percentile was 10.2mg/m3. In fact, in only 1 day didPM2.5
exceed 35 mg/m3 in Boston during the study timeframe. The
averagePM2.5 during the study periodwas<60%of the current
EPA annual average standard of 15 mg/m3. The exposure
response shown in this study suggests that in cities with higher
levels of pollution, the risk of AF may be even greater. Thus,
these results raise important public health implications in that
even low levels of air pollution such as that seen in Boston are
associated with an increased occurrence of AF episodes.
Prior data linking air pollution to atrial arrhythmias are
limited by a short duration of monitoring or incomplete
monitoring of atrial arrhythmias. Incomplete arrhythmia
monitoring is demonstrated by a subanalysis of an earlier
study of Boston ICD patients that reported associations of
air pollution with atrial arrhythmias (21). In this study, most
patients had a single chamber ICD (ventricular) and thus
only rapid AF such as would activate the ventricular
arrhythmia zone were recorded. Consequently, these
episodes were a highly selected subset of AF and likely were
a minority of the atrial arrhythmia episodes.
Other studies on the association of atrial arrhythmias and
air pollution utilize short and intermittent cardiac moni-
toring. For example, in a 24-week, 30 min/week Holter
study of 32 adults in Ohio, 5-day moving averages of PM2.5,
sulfate and ozone were associated with an increased odds of
supraventricular ectopy (23). In a 4-week, 24 h/week Holter
study of 57 German men with coronary artery disease,
elevated concentrations of particulate matter and NO2 in the
prior 24 h were associated with increased risk for atrial runs
(24). In another study monitoring PR prolongation and P-
wave complexity, possible predictors of AF, were associated
with PM2.5 in the prior 24 h (22). No prior study to our
knowledge has utilized such an extended time period of
follow-up with complete monitoring for all AF as was done
in the current study.Study limitations. As in many air pollution studies there are
limitations to single-site air quality monitoring. Single-site
ambient monitoring may lead to exposure misclassiﬁcation.
Exposure misclassiﬁcation is less likely with PM2.5 because of
the regional spatial homogeneity of this pollutant. Other
pollutants with less spatial homogeneity may have weaker
associations because of exposure misclassiﬁcation. To over-
come this issue we also analyzed only patients residing within
26 km of the monitoring station. In this analysis the effect of
PM2.5, BC, and NO2 were strong but with wider conﬁdence
intervals. The association with sulfate, PNC, SO2, and O3
remained weak and far from statistical signiﬁcance.
Given the number of statistical tests performed (7 pol-
lutants with 5 different lag times) it is possible that some of
our results may be due to chance. However, the strongest
associations were seen for the set of air pollutants indicative
of motor vehicle exhaust. These associations were strongest
for the 2-h window prior to the AF and decreased with
increasing lag times. There was also a dose dependent
association with PM2.5 in that higher pollutants levels had
an increased odds of AF. For these reasons we believe these
results present a coherent, biologically plausible evidence of
a true association that is not due to chance.
A signiﬁcant proportion of the study population (29%)
had episodic AF prior to their enrollment. The prior history
of AF is surely 1 of the strongest risk factors for AF; thus
these individuals are at particularly high risk for AF. Yet, it
appears that air pollution may initiate a speciﬁc episode in
these individuals. In analysis restricted to those patients
without a prior history of AF the results were unchanged
compared to the entire group (Fig. 5). Patients in this study
were at higher risk of AF because of their underlying heart
disease and reduced left ventricular ejection fraction.
However, AF is the most common arrhythmia in the United
States and age is 1 of the strongest risk factors, yet it is
unknown whether these results are relevant to other pop-
ulations also at risk for AF.
This study evaluated the acute onset of AF, not the duration
or total time in AF. The total duration of AF may be more
important than the number of episodes of AF. This current
study focused on AF and not on ventricular arrhythmias.
Conclusions
In this high-risk population, ambient air pollution increased
the occurrence of AF episodes. Importantly, the air pollution–
associated increase in AF demonstrated an exposure response
risk of AF with worsening air quality, even in a city with air
quality which is within the EPA-mandated levels. Because
AF is associated with stroke and cardiovascular disease, it is
likely that AF contributes to the adverse outcomes of air
pollution seen in epidemiologic studies.
Acknowledgments
The authors would like to thank Michaela Owen, Melanie
E. Marshall, and Brandon Udelhofen for their work on
Link et al. JACC Vol. 62, No. 9, 2013
Air Pollution and Atrial Fibrillation August 27, 2013:816–25
824this project. They were instrumental in the enrollment,
follow-up, and data collection of patients.
Reprint requests and correspondence: Dr. Mark S. Link, Tufts
Medical Center, Box #197, 800 Washington Street, Boston,
Massachusetts 02459. E-mail: mlink@tuftsmedicalcenter.org.
REFERENCES
1. Dockery DW. Epidemiologic evidence of cardiovascular effects of
particulate air pollution. Environ Health Perspect 2001;109 Suppl 4:
483–6.
2. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air
pollution and cardiovascular disease: An update to the scientiﬁc statement
from the American Heart Association. Circulation 2010;121:2331–78.
3. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovas-
cular disease: a statement for healthcare professionals from the Expert
Panel on Population and Prevention Science of the American Heart
Association. Circulation 2004;109:2655–71.
4. Link MS, Dockery DW. Air pollution and the triggering of cardiac
arrhythmias. Curr Opin Cardiol 2010;25:16–22.
5. Zanobetti A, Schwartz J. The effect of particulate air pollution on
emergency admissions for myocardial infarction: a multicity case-
crossover analysis. Environ Health Perspect 2005;113:978–82.
6. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased
particulate air pollution and the triggering of myocardial infarction.
Circulation 2001;103:2810–5.
7. Forastiere F, Stafoggia M, Picciotto S, et al. A case-crossover analysis
of out-of-hospital coronary deaths and air pollution in Rome, Italy. Am
J Respir Crit Care Med 2005;172:1549–55.
8. Rosenthal FS, Carney JP, Olinger ML. Out-of-hospital cardiac arrest
and airborne ﬁne particulate matter: a case-crossover analysis of
emergency medical services data in Indianapolis, Indiana. Environ
Health Perspect 2008;116:631–6.
9. Levy D, Sheppard L, Checkoway H, et al. A case-crossover analysis of
particulate matter air pollution and out-of-hospital primary cardiac
arrest. Epidemiology 2001;12:193–9.
10. Pope CA 3rd, Dockery DW. Health effects of ﬁne particulate air
pollution: lines that connect. J Air Waste Manag Assoc 2006;56:
709–42.
11. Wellenius GA, Schwartz J, Mittleman MA. Air pollution and hospital
admissions for ischemic and hemorrhagic stroke among medicare
beneﬁciaries. Stroke 2005;36:2549–53.
12. O’Donnell MJ, Fang J, Mittleman MA, Kapral MK, Wellenius GA.
Fine particulate air pollution (PM2.5) and the risk of acute ischemic
stroke. Epidemiology 2011;22:422–31.
13. Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air
pollution and incidence of cardiovascular events in women. N Engl J
Med 2007;356:447–58.
14. Pope CA 3rd, Burnett RT, Thurston GD, et al. Cardiovascular
mortality and long-term exposure to particulate air pollution: epide-
miological evidence of general pathophysiological pathways of disease.
Circulation 2004;109:71–7.
15. Wellenius GA, Burger MR, Coull BA, et al. Ambient air pollution and
the risk of acute ischemic stroke. Arch Intern Med 2012;172:229–34.
16. Rich DQ, Kim MH, Turner JR, et al. Association of ventricular
arrhythmias detected by implantable cardioverter deﬁbrillator and
ambient air pollutants in the St Louis, Missouri metropolitan area.
Occup Environ Med 2006;63:591–6.
17. Dockery DW, Luttmann-Gibson H, Rich DQ, et al. Association of air
pollution with increased incidence of ventricular tachyarrhythmias
recorded by implanted cardioverter deﬁbrillators. Environ Health
Perspect 2005;113:670–4.
18. Anderson HR, Armstrong B, Hajat S, et al. Air pollution and acti-
vation of implantable cardioverter deﬁbrillators in London. Epidemi-
ology 2010;21:405–13.
19. Ljungman PL, Berglind N, Holmgren C, et al. Rapid effects of air
pollution on ventricular arrhythmias. Eur Heart J 2008;29:2894–901.
20. Metzger KB, Klein M, Flanders WD, et al. Ambient air pollution and
cardiac arrhythmias in patients with implantable deﬁbrillators. Epide-
miology 2007;18:585–92.21. Rich DQ, Mittleman MA, Link MS, et al. Increased risk of parox-
ysmal atrial ﬁbrillation episodes associated with acute increases in
ambient air pollution. Environ Health Perspect 2006;114:120–3.
22. Liao D, Shaffer ML, He F, et al. Fine particulate air pollution is
associated with higher vulnerability to atrial ﬁbrillationdthe APACR
study. J Toxicol Environ Health 2011;74:693–705.
23. Sarnat SE, Suh HH, Coull BA, Schwartz J, Stone PH, Gold DR.
Ambient particulate air pollution and cardiac arrhythmia in a panel of
older adults in Steubenville, Ohio. Occup Environ Med 2006;63:700–6.
24. Berger A, Zareba W, Schneider A, et al. Runs of ventricular and
supraventricular tachycardia triggered by air pollution in patients with
coronary heart disease. J Occup Environ Med 2006;48:1149–58.
25. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for
atrial ﬁbrillation and heart failure. N Engl J Med 2008;358:2667–77.
26. Risk factors for stroke and efﬁcacy of antithrombotic therapy in atrial
ﬁbrillation. Analysis of pooled data from ﬁve randomized controlled
trials. Arch Intern Med 1994;154:1449–57.
27. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006
guidelines for the management of patients with atrial ﬁbrillation:
a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines and the European
Society of Cardiology Committee for Practice Guidelines (Writing
Committee to Revise the 2001 Guidelines for the Management of
Patients With Atrial Fibrillation): developed in collaboration with the
European Heart Rhythm Association and the Heart Rhythm Society.
J Am Coll Cardiol 2006;48:e149–246.
28. Roy D, Talajic M, Dubuc M, et al. Atrial ﬁbrillation and congestive
heart failure. Curr Opin Cardiol 2009;24:29–34.
29. Santini M, Gasparini M, Landolina M, et al. Device-detected atrial
tachyarrhythmias predict adverse outcome in real-world patients with
implantable biventricular deﬁbrillators. J Am Coll Cardiol 2011;57:
167–72.
30. Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular
events in initially healthy women with new-onset atrial ﬁbrillation.
JAMA 2011;305:2080–7.
31. McManus DD, Rienstra M, Benjamin EJ. An update on the prognosis
of patients with atrial ﬁbrillation. Circulation 2012;126:e143–6.
32. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial ﬁbrillation
and the risk of stroke. N Engl J Med 2012;366:120–9.
33. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert
consensus statement on catheter and surgical ablation of atrial ﬁbrillation:
recommendations for personnel, policy, procedures and follow-up. A
report of the Heart Rhythm Society (HRS) Task Force on catheter and
surgical ablation of atrial ﬁbrillation. Heart Rhythm 2007;4:816–61.
34. Estes NA 3rd, Halperin JL, Calkins H, et al. ACC/AHA/Physician
Consortium 2008 clinical performance measures for adults with non-
valvular atrial ﬁbrillation or atrial ﬂutter: a report of the American
College of Cardiology/American Heart Association Task Force on
Performance Measures and the Physician Consortium for Performance
Improvement (Writing Committee to Develop Clinical Performance
Measures for Atrial Fibrillation): developed in collaboration with the
Heart Rhythm Society. J Am Coll Cardiol 2008;51:865–84.
35. Schwartz J. The distributed lag between air pollution and daily deaths.
Epidemiology 2000;11:320–6.
36. Maclure M. The case-crossover design: a method for studying transient
effects on the risk of acute events. Am J Epidemiol 1991;133:144–53.
37. Neas LM, Schwartz J, Dockery D. A case-crossover analysis of air
pollution and mortality in Philadelphia. Environ Health Perspect 1999;
107:629–31.
38. Sunyer J, Schwartz J, Tobias A, Macfarlane D, Garcia J, Anto JM.
Patients with chronic obstructive pulmonary disease are at increased
risk of death associated with urban particle air pollution: a case-
crossover analysis. Am J Epidemiol 2000;151:50–6.
39. Lee JT, Schwartz J. Reanalysis of the effects of air pollution on daily
mortality in Seoul, Korea: a case-crossover design. Environ Health
Perspect 1999;107:633–6.
40. Mittleman MA, Maclure M, Robins JM. Control sampling strategies
for case-crossover studies: an assessment of relative efﬁciency. Am J
Epidemiol 1995;142:91–8.
41. Levy D, Lumley T, Sheppard L, Kaufman J, Checkoway H. Referent
selection in case-crossover analyses of acute health effects of air
pollution. Epidemiology 2001;12:186–92.
42. Bettoni M, Zimmermann M. Autonomic tone variations before the
onset of paroxysmal atrial ﬁbrillation. Circulation 2002;105:2753–9.
JACC Vol. 62, No. 9, 2013 Link et al.
August 27, 2013:816–25 Air Pollution and Atrial Fibrillation
82543. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is
a major determinant of sustained atrial arrhythmias in patients with
focal ectopy originating from the pulmonary veins. J Cardiovasc Elec-
trophysiol 2001;12:285–91.
44. Schauerte P, Scherlag BJ, Patterson E, et al. Focal atrial ﬁbrillation:
experimental evidence for a pathophysiologic role of the autonomic
nervous system. J Cardiovasc Electrophysiol 2001;12:592–9.
45. Lombardi F, Tarricone D, Tundo F, Colombo F, Belletti S,
Fiorentini C. Autonomic nervous system and paroxysmal atrial ﬁbrilla-
tion: a study based on the analysis of RR interval changes before, during
and after paroxysmal atrial ﬁbrillation. Eur Heart J 2004;25:1242–8.
46. Sata N, Hamada N, Horinouchi T, et al. C-reactive protein and atrial
ﬁbrillation. Is inﬂammation a consequence or a cause of atrial ﬁbrilla-
tion? Jpn Heart J 2004;45:441–5.
47. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inﬂammation as
a risk factor for atrial ﬁbrillation. Circulation 2003;108:3006–10.
48. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein eleva-
tion in patients with atrial arrhythmias: inﬂammatory mechanisms and
persistence of atrial ﬁbrillation. Circulation 2001;104:2886–91.
49. White CW, Kerber RE, Weiss HR, Marcus ML. The effects of atrial
ﬁbrillation on atrial pressure-volume and ﬂow relationships. Circ Res
1982;51:205–15.
50. Kamkin A, Kiseleva I, Wagner KD, Lozinsky I, Gunther J,
Scholz H. Mechanically induced potentials in atrial ﬁbroblasts from
rat hearts are sensitive to hypoxia/reoxygenation. Pﬂugers Arch 2003;
446:169–74.
51. Zanobetti A, Gold DR, Stone PH, et al. Reduction in heart rate
variability with trafﬁc and air pollution in patients with coronary artery
disease. Environ Health Perspect 2010;118:324–30.
52. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart
rate variability. Circulation 2000;101:1267–73.
53. Schwartz J, Litonjua A, Suh H, et al. Trafﬁc related pollution and
heart rate variability in a panel of elderly subjects. Thorax 2005;60:
455–61.
54. Chen LC, Hwang JS. Effects of subchronic exposures to concentrated
ambient particles (CAPs) in mice. IV. Characterization of acute and
chronic effects of ambient air ﬁne particulate matter exposures on heart-
rate variability. Inhalat Toxicol 2005;17:209–16.55. Corey LM, Baker C, Luchtel DL. Heart-rate variability in the apoli-
poprotein E knockout transgenic mouse following exposure to Seattle
particulate matter. J Toxicol Environ Health 2006;69:953–65.
56. Peters A, Frohlich M, Doring A, et al. Particulate air pollution is
associated with an acute phase response in men; results from the
MONICA-Augsburg Study. Eur Heart J 2001;22:1198–204.
57. Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW.
Daily concentrations of air pollution and plasma ﬁbrinogen in London.
Occup Environ Med 2000;57:818–22.
58. Schwartz J. Air pollution and blood markers of cardiovascular risk.
Environ Health Perspect 2001;109 Suppl 3:405–9.
59. Pekkanen J, Peters A, Hoek G, et al. Particulate air pollution and risk
of ST-segment depression during repeated submaximal exercise tests
among subjects with coronary heart disease: the Exposure and Risk
Assessment for Fine and Ultraﬁne Particles in Ambient Air (ULTRA)
study. Circulation 2002;106:933–8.
60. Delﬁno RJ, Gillen DL, Tjoa T, et al. Electrocardiographic ST-segment
depression and exposure to trafﬁc-related aerosols in elderly subjects with
coronary artery disease. Environ Health Perspect 2011;119:196–202.
61. Rich DQ, Freudenberger RS, Ohman-Strickland P, Cho Y, Kipen HM.
Right heart pressure increases after acute increases in ambient particulate
concentration. Environ Health Perspect 2008;116:1167–71.
62. Zanobetti A, Stone PH, Speizer FE, et al. T-wave alternans, air pollu-
tion and trafﬁc in high-risk subjects. Am J Cardiol 2009;104:665–70.
63. Lokken RP, Wellenius GA, Coull BA, et al. Air pollution and risk of
stroke: underestimation of effect due to misclassiﬁcation of time of
event onset. Epidemiology 2009;20:137–42.
64. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke
statisticsd2008 update: a report from the American Heart Association
Statistics Committee and Stroke Statistics Subcommittee. Circulation
2008;117:e25–146.
65. Environment Protection Agency. National Ambient Air Quality
Standards for Particulate Matter 2006:61144–233. Available at: http://
www.safca.org/documents/Folsom%20Dam%20Joint%20Federal%20
Project/09DEC.MIAD.DRAFT.EIS.EIR.pdf. Accessed July 2013.Key Words: air pollution - atrial ﬁbrillation - particulate matter - trafﬁc.
